| Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation GJ Freeman, JG Gribben, VA Boussiotis, JW Ng, VA Restivo Jr, ... Science 262 (5135), 909-911, 1993 | 1304 | 1993 |
| ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia LZ Rassenti, L Huynh, TL Toy, L Chen, MJ Keating, JG Gribben, ... New England Journal of Medicine 351 (9), 893-901, 2004 | 1215 | 2004 |
| Genetic and functional drivers of diffuse large B cell lymphoma A Reddy, J Zhang, NS Davis, AB Moffitt, CL Love, A Waldrop, S Leppa, ... Cell 171 (2), 481-494. e15, 2017 | 1045 | 2017 |
| Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma JG Gribben, AS Freedman, D Neuberg, DC Roy, KW Blake, SD Woo, ... New England Journal of Medicine 325 (22), 1525-1533, 1991 | 885 | 1991 |
| The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee E Campo, ES Jaffe, JR Cook, L Quintanilla-Martinez, SH Swerdlow, ... Blood, The Journal of the American Society of Hematology 140 (11), 1229-1253, 2022 | 850 | 2022 |
| Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. CD Gimmi, GJ Freeman, JG Gribben, G Gray, LM Nadler Proceedings of the National Academy of Sciences 90 (14), 6586-6590, 1993 | 808 | 1993 |
| Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma J Okosun, C Bödör, J Wang, S Araf, CY Yang, C Pan, S Boller, D Cittaro, ... Nature genetics 46 (2), 176-181, 2014 | 778 | 2014 |
| Chronic lymphocytic leukaemia TJ Kipps, FK Stevenson, CJ Wu, CM Croce, G Packham, WG Wierda, ... Nature reviews Disease primers 3 (1), 1-22, 2017 | 744 | 2017 |
| Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug AG Ramsay, AJ Johnson, AM Lee, G Gorgün, R Le Dieu, W Blum, JC Byrd, ... The Journal of clinical investigation 118 (7), 2427-2437, 2008 | 734 | 2008 |
| Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label … C Moreno, R Greil, F Demirkan, A Tedeschi, B Anz, L Larratt, M Simkovic, ... The Lancet Oncology 20 (1), 43-56, 2019 | 644 | 2019 |
| B-cell surface antigen B7 provides a costimulatory signal that induces T cells to proliferate and secrete interleukin 2. CD Gimmi, GJ Freeman, JG Gribben, K Sugita, AS Freedman, C Morimoto, ... Proceedings of the National Academy of Sciences 88 (15), 6575-6579, 1991 | 627 | 1991 |
| T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production JC Riches, JK Davies, F McClanahan, R Fatah, S Iqbal, S Agrawal, ... Blood, The Journal of the American Society of Hematology 121 (9), 1612-1621, 2013 | 598 | 2013 |
| Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma A Ene–Obong, AJ Clear, J Watt, J Wang, R Fatah, JC Riches, JF Marshall, ... Gastroenterology 145 (5), 1121-1132, 2013 | 564 | 2013 |
| Transplantation of anergic histoincompatible bone marrow allografts EC Guinan, VA Boussiotis, D Neuberg, LLV Brennan, N Hirano, ... New England Journal of Medicine 340 (22), 1704-1714, 1999 | 562 | 1999 |
| Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. GJ Freeman, GS Gray, CD Gimmi, DB Lombard, LJ Zhou, M White, ... The Journal of experimental medicine 174 (3), 625-631, 1991 | 539 | 1991 |
| Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. GJ Freeman, F Borriello, RJ Hodes, H Reiser, JG Gribben, JW Ng, J Kim, ... The Journal of experimental medicine 178 (6), 2185-2192, 1993 | 521 | 1993 |
| Rituximab and CHOP induction therapy for newly diagnosed mantle-cell lymphoma: molecular complete responses are not predictive of progression-free survival OM Howard, JG Gribben, DS Neuberg, M Grossbard, C Poor, MJ Janicek, ... Journal of Clinical Oncology 20 (5), 1288-1294, 2002 | 516 | 2002 |
| Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity EC Guinan, JG Gribben, VA Boussiotis, GJ Freeman, LM Nadler | 502 | 1994 |
| Anti-CD38 antibody–mediated clearance of human repopulating cells masks the heterogeneity of leukemia-initiating cells DC Taussig, F Miraki-Moud, F Anjos-Afonso, DJ Pearce, K Allen, C Ridler, ... Blood, The Journal of the American Society of Hematology 112 (3), 568-575, 2008 | 483 | 2008 |
| CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. JL Schultze, S Michalak, MJ Seamon, G Dranoff, K Jung, J Daley, ... The Journal of clinical investigation 100 (11), 2757-2765, 1997 | 454 | 1997 |
